PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to stop the itch of prurigo nodularis
Disease control OngoingThis phase 3 trial tests an oral drug called povorcitinib in 346 adults with prurigo nodularis, a condition causing intense itching and bumpy skin lesions. Participants receive either the drug or a placebo for 24 weeks. The study measures whether the drug reduces itch severity an…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Real-World dupilumab study aims to ease chronic itch
Disease control OngoingThis study follows 100 adults with prurigo nodularis who are already prescribed dupilumab (Dupixent) by their doctor. Researchers will track why patients start or stop the drug, how well it controls itching and skin bumps, and any hospital visits. The goal is to see how dupilumab…
Matched conditions: PRURIGO NODULARIS
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:00 UTC
-
New drug could soothe uncontrollable itch in rare skin condition
Symptom relief OngoingThis phase 3 trial tests an oral drug called povorcitinib in 349 adults with prurigo nodularis, a condition causing intense itching and hard skin bumps. Participants receive either the drug or a placebo for 24 weeks. The goal is to see if the drug reduces itch and clears skin les…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New drug aims to calm relentless itch of prurigo nodularis
Symptom relief OngoingThis phase 3 study tests rocatinlimab, an injectable drug, against a placebo in 469 adults with prurigo nodularis—a condition causing intense itching and hard bumps on the skin. Participants had not gotten enough relief from topical treatments. The main goal is to see if the drug…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New shot aims to stop the itch of prurigo nodularis
Symptom relief OngoingThis phase 2 trial tests a drug called barzolvolimab in 140 adults with prurigo nodularis, a skin condition causing intense itching and hard bumps. Participants receive either the drug or a placebo as a shot under the skin. The main goal is to see if the drug reduces itch severit…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug shows promise for chronic itch in Long-Term trial
Symptom relief OngoingThis study looks at the long-term safety of nemolizumab in 500 adults with prurigo nodularis, a condition causing severe itching and skin bumps. Participants must have taken nemolizumab in a previous study. The main goal is to track side effects over time, while also checking if …
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC